RPID
RAPID MICRO BIOSYSTEMS, INC.
NASDAQ · Healthcare · Medical - Devices · US
$0.77
+1.20%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$0.80
From 52W high−83.47%
Volume198061.00
Market cap$38.80M
P/E (TTM)—
P/S (TTM)1.1x
Div yield—
Key dataOct 19, 2026
Open
$0.80
From 52W high
−83.47%
Volume
198061.00
Market cap
$38.80M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.9x
P/E (TTM)
—
RSI (14)
23.8
MomentumView details →
1D Return
+1.20%
YTD Return
−73.14%
SummaryUpdated Jun 1, 2026
Rapid Micro Biosystems, Inc. (NASDAQ:RPID) is a life sciences technology company founded in 2006 and headquartered in Lowell, Massachusetts. Originally incorporated as Genomic Profiling Systems, Inc., the company changed its name to Rapid Micro Biosystems in January 2007 and went public in July 2021. The company specializes in automating microbial quality control testing for pharmaceutical, medical device, and personal care manufacturers through its flagship Growth Direct platform, which modernizes traditional manual testing workflows that have remained largely unchanged for decades.
Similar companies
Latest newsMore news →